Pfizer

After Johnson & Johnson allied itself with Aspen, it is Pfizer / BioNTech's turn to partner with a South African company to produce its anticovid vaccine. The manufacturer has signed an agreement with the Biovac Institute, a semi-state company based in Cape Town. This will be the first time a Messenger RNA vaccine has been produced in Africa. Target: 100 million doses per year by 2023. Production…

JERUSALEM - The coronavirus variant discovered in South Africa may "carry through" Pfizer / BioNTech's COVID-19 vaccine to some degree, according to a real-world data study in Israel, although its prevalence in the country is low and research has not been peer-reviewed. The study, published Saturday, compared nearly 400 people who had tested positive for COVID-19, 14 days or more after receiving one or two doses of the vaccine against the same number of unvaccinated patients with the disease. It matched, among other…